1.

A 120,000-watt magnetic coil just rewarmed 2 liters of cryoprotectant from −150°C in 2 minutes — with less than 5°C of temperature difference across the entire volume. The physics of freezing human organs has been solved. The biology hasn't been touched.

2.

Convective cooling hits a wall at organ scale

• 1.5 L vitrification was attempted and failed by 1990 — ice formed and the glassy material fractured from thermal stress
• Cooling rates at the center of a sample decrease as volume increases: ~1.4°C/min at 0.5 L, ~0.5°C/min at 3 L
• The critical cooling rate of VS55 (~2.5°C/min) exceeded all achievable rates, and ice formed in every VS55 trial at every volume

3.

Annealing and slow cooling prevent fracture in the glassy state

• After reaching −122°C (just above the glass transition temperature), the system was annealed — thermally equilibrated to relieve gradients before the material became brittle
• Slow cooling below Tg (<1°C/min) kept temperature differences below 20°C, the fracture threshold calculated from a thermal shock equation
• Protocols extended to ~12 hours for 3 L, highlighting that convective cooling alone will be the rate-limiting step for human organs

4.

A 120 kW RF coil heats 2.5 L uniformly from the inside

• Magnetic iron-oxide nanoparticles (IONPs) perfused through organ vasculature generate heat via magnetic hysteresis when exposed to a 360 kHz alternating magnetic field
• The new coil delivers 35 kA/m across a 2.5 L uniform field region — 31× the volume of the prior 15 kW system's ~80 mL region
• SAR increased ~1.5× at cryogenic temperature versus room temperature, likely due to higher magnetic susceptibility and reduced specific heat in the glassy state

5.

Nanowarming rates scale with IONP concentration, not volume

• 1 L rewarmed to 0°C in ~1 minute at ~172°C/min with 10.7 mgFe/mL; 2 L rewarmed in ~2 minutes at ~88°C/min with 4.6 mgFe/mL — rates were identical at equal concentrations
• Temperature differences across the cryobag were negligible (~<5°C) in all cases, eliminating the thermal stress that fractures conventionally rewarmed samples
• At 100 mgFe/mL, a 1 mL cryovial hit ~1500°C/min — the fastest nanowarming rate ever measured, confirming linear scaling with concentration

6.

Porcine liver vitrification proves the protocol works on an organ

• A ~1 L porcine liver (comparable to a juvenile human liver) was perfused with 40%EG + 0.6 M sucrose and vitrified using the 0.5 L cryobag cooling protocol
• Modeling predicted a center cooling rate of ~4°C/min, exceeding the CPA's CCR of ~1°C/min; visual inspection, bisected photos, and µCT confirmed ice-free tissue
• Small ice formed only around the portal vein and fatty perihilar tissue — poorly vascularized regions that presumably didn't equilibrate with the CPA

7.

The entire demonstration is physics, not medicine

• No biological assessment was performed on any vitrified organ — no cell viability, no functional recovery, no transplantation outcome. The authors state this explicitly: "As this work is focused solely on assessing the feasibility for physical vitrification and nanowarming success, the toxicity of specific CPAs in specific organs will be addressed elsewhere."
• The porcine liver was never nanowarmed — the 120 kW coil's diameter was too small for the organ's horizontal dimensions. The only organ nanowarmed in the study was a rat kidney from a prior paper, at 30 mL. The central claim of liter-scale organ nanowarming has been demonstrated on cryoprotectant solutions, not organs.
• The 92–94% CPA equilibration in tissue, acknowledged by the authors, means the effective CPA concentration inside an organ is lower than the bulk solution. This raises the critical cooling rate, making vitrification harder — and the authors' own Figure 8 shows that at 3 L, the minimum vitrifiable CPA concentration (~62% w/w) is barely below M22's ~66% w/w. The margin for error is razor-thin.

8.

The physics is the hard part — and it's done

• Both the thesis and the counter-argument share a hidden assumption: that physical and biological success must be demonstrated simultaneously. But the history of cryopreservation says otherwise — the first frog sperm was vitrified in 1938, and the first human embryo was cryopreserved in 1983. The physics was solved decades before the biology caught up.
• The 120 kW coil's 2.5 L uniform field region is not a lab curiosity — it is a clinical-scale device. The 3 L vitrification and 2 L nanowarming demonstrations are not incremental improvements; they are the first time anyone has physically cleared the volume barrier that has blocked organ banking for sixty years.
• The real question is not whether this paper proves organ transplantation works. It is whether the rate-limiting step has shifted from physics to biology. If it has, then the next decade of research is no longer about building bigger coils or cooling faster — it is about making CPAs less toxic and perfusion more complete. That is a fundamentally different, and arguably more tractable, problem.